BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.69B |
| 2 |
Apple
AAPL
|
+$892M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
+$799M |
| 4 |
Industrial Select Sector SPDR Fund
XLI
|
+$793M |
| 5 |
GE Aerospace
GE
|
+$748M |
Top Sells
| 1 |
Tesla
TSLA
|
+$362M |
| 2 |
Utilities Select Sector SPDR Fund
XLU
|
+$345M |
| 3 |
NVIDIA
NVDA
|
+$258M |
| 4 |
MetLife
MET
|
+$257M |
| 5 |
Meta Platforms (Facebook)
META
|
+$223M |
Sector Composition
| 1 | Technology | 26.74% |
| 2 | Consumer Discretionary | 11.23% |
| 3 | Financials | 10.63% |
| 4 | Healthcare | 8.41% |
| 5 | Communication Services | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Atomera
ATOM
$103M
| $25.1K | ﹤0.01% |
2,162
-737
| -25% | -$8.55K |
|
3652
W&T Offshore
WTI
$258M
| $25.1K | ﹤0.01% |
15,101
-122,928
| -89% | -$204K |
|
|
RAPP
3653
Rapport Therapeutics
RAPP
$847M
| $25K | ﹤0.01% |
1,412
-272
| -16% | -$4.83K |
|
3654
Larimar Therapeutics
LRMR
$357M
| $25K | ﹤0.01% |
+6,465
| New | +$25K |
|
3655
Occidental Petroleum Corporation Warrants to Purchase Common Stock
OXY.WS
$22.8B
| $25K | ﹤0.01% |
908
| – | – |
|
3656
Security National Financial
SNFCA
$231M
| $25K | ﹤0.01% |
2,181
-431
| -17% | -$4.94K |
|
3657
Cadiz
CDZI
$295M
| $25K | ﹤0.01% |
4,804
-15,582
| -76% | -$81K |
|
3658
Cardiff Oncology
CRDF
$138M
| $24.9K | ﹤0.01% |
+5,733
| New | +$24.9K |
|
|
UPB
3659
Upstream Bio, Inc. Common Stock
UPB
$966M
| $24.8K | ﹤0.01% |
+1,511
| New | +$24.8K |
|
|
LAC
3660
Lithium Americas
LAC
$686M
| $24.7K | ﹤0.01% |
8,315
-80,235
| -91% | -$238K |
|
3661
ReNew
RNW
$2.78B
| $24.7K | ﹤0.01% |
+3,612
| New | +$24.7K |
|
3662
AlTi Global
ALTI
$394M
| $24.7K | ﹤0.01% |
+5,590
| New | +$24.7K |
|
3663
SEACOR Marine Holdings
SMHI
$171M
| $24.6K | ﹤0.01% |
3,756
-1,589
| -30% | -$10.4K |
|
3664
Ferrovial SE
FER
$41.1B
| $24.6K | ﹤0.01% |
+586
| New | +$24.6K |
|
3665
Defiance Quantum ETF
QTUM
$2.13B
| $24.3K | ﹤0.01% |
+300
| New | +$24.3K |
|
3666
C4 Therapeutics
CCCC
$194M
| $24.3K | ﹤0.01% |
+6,742
| New | +$24.3K |
|
|
SEVN
3667
Seven Hills Realty Trust
SEVN
$162M
| $24.3K | ﹤0.01% |
+1,854
| New | +$24.3K |
|
3668
Medallion Financial
MFIN
$244M
| $24.1K | ﹤0.01% |
2,566
-2,254
| -47% | -$21.2K |
|
3669
Acacia Research
ACTG
$304M
| $24.1K | ﹤0.01% |
5,550
-2,013
| -27% | -$8.74K |
|
3670
Full House Resorts
FLL
$120M
| $24K | ﹤0.01% |
5,876
-1,729
| -23% | -$7.05K |
|
3671
Evogene
EVGN
$11.2M
| $24K | ﹤0.01% |
12,819
+619
| +5% | +$1.16K |
|
3672
Geospace Technologies
GEOS
$211M
| $23.9K | ﹤0.01% |
2,383
-633
| -21% | -$6.34K |
|
3673
Telos
TLS
$505M
| $23.8K | ﹤0.01% |
+6,961
| New | +$23.8K |
|
3674
Virginia National Bankshares
VABK
$218M
| $23.8K | ﹤0.01% |
+623
| New | +$23.8K |
|
3675
Northern Technologies International Corp
NTIC
$74.8M
| $23.7K | ﹤0.01% |
1,756
-12,206
| -87% | -$165K |
|